CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
13.52
+0.10 (0.75%)
Nov 20, 2024, 4:00 PM EST - Market closed
CVRx, Inc. Revenue
CVRx, Inc. had revenue of $13.37M in the quarter ending September 30, 2024, with 27.23% growth. This brings the company's revenue in the last twelve months to $47.26M, up 34.38% year-over-year. In the year 2023, CVRx, Inc. had annual revenue of $39.30M with 74.89% growth.
Revenue (ttm)
$47.26M
Revenue Growth
+34.38%
P/S Ratio
6.19
Revenue / Employee
$236,275
Employees
200
Market Cap
328.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 39.30M | 16.83M | 74.89% |
Dec 31, 2022 | 22.47M | 9.43M | 72.36% |
Dec 31, 2021 | 13.04M | 6.98M | 115.36% |
Dec 31, 2020 | 6.05M | -204.00K | -3.26% |
Dec 31, 2019 | 6.26M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Spok Holdings | 137.71M |
Sanara MedTech | 78.06M |
AC Immune | 48.51M |
Alpha Teknova | 36.35M |
Aclaris Therapeutics | 27.08M |
Delcath Systems | 22.64M |
Silence Therapeutics | 21.77M |
Nano-X Imaging | 10.13M |
CVRX News
- 16 hours ago - CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 14 days ago - CVRx: Impressive Top-Line Growth Seems Priced In - Seeking Alpha
- 22 days ago - CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - CVRx announces new CPT® Category I codes for Barostim - GlobeNewsWire
- 5 weeks ago - CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024 - GlobeNewsWire
- 2 months ago - CVRx Announces Appointment of Two New Board Members - GlobeNewsWire
- 3 months ago - CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - GlobeNewsWire
- 3 months ago - The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join - Accesswire